Aurora kinase inhibitor Hesperadin, Purity ≥98%

Cat. No.: X23-10-ZQ470

Aurora kinase inhibitor Hesperadin, Purity ≥98%

Synonym: Hesperadin; 422513-13-1; hesperadine; UNII-PTR491OS14; CHEBI:70726; TCMDC-135395; CHEMBL514409; Aurora kinase inhibitor

  • MDL: MFCD18074526
  • CAS Number: 422513-13-1
  • Compound CID: 135421442
Product Size
5 mg; 10 mg; 25 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
Hesperadin, soluble in DMSO and insoluble in ethanol and water, is an Aurora kinase inhibitor that disrupts cell division processes. It targets Aurora B (human) and TbAUK1.
Molecular Weight
516.7
Molecular Formula
C29H32N4O3S
Targets
Aurora B (Human): 250 nM; TbAUK1: 40 nM
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 100 mg/mL (193.55 mM); Water: Insoluble; Ethanol: Insoluble
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
Hesperadin is employed to study the effects of Aurora B kinase inhibition on chromosome alignment and segregation.
Storage
Store at -20ºC.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.